LRCX's Q4 earnings report is a free, dated, two-week-early read on the single risk that would de-rate IREN’s valuation ...

Two sizable IPOs and one direct listing are currently scheduled in the week ahead, although some smaller deals may also join ...

Quantum computing is moving beyond theory, with BQP using quantum optimization to redesign drone propellers in ways ...

Sezzle (SEZL) hits record Q1 FY26 GMV, revenue and net income, raises FY26 guidance, and stays bullish despite risks. See ...

Oscar Health (OSCR) is up 100%+ since April, yet trades at a 0.50 forward P/S—80%+ undervalued. Read here for a detailed ...

Q2: record loan production, strong credit, raised FY26 guidance. Hold rating as valuation looks full. See more details here.

Levi Strauss is poised for continued outperformance, driven by robust sales momentum and a compelling valuation. LEVI's Q2 ...

SPCX stock is down 50% below IPO—a contrarian setup fueled by profitable Starlink growth, high short interest, and Q2 ...

Dupixent & Libtayo fuel growth despite volatility & Eylea biosimilar risks; margins to recover. Click for an REGN update.

According to the Census Bureau, new home sales were at a seasonally adjusted annual rate of 628,000 in June. This represents ...

Hycroft Mining presents an impressive $4.3B NPV5 and 51-year mine life, but lacks production, reserves, and a construction ...

US-Iran tensions raise fat-tail risks for oil as US/Japan/Europe reserves near depletion; meme stocks like TSLA, PLTR ...